- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 10 - Clinical Trials and Patients' Role
Dr Chernew asks panelists how patients might learn about clinical trials, and how trials handle treatment placebos.
Dr Chernew asks panelists how patients might learn about clinical trials, and how trials handle treatment placebos.
Ms Young says that some patients find out about trials through their doctor, but it is difficult to reach patients in the greater community. Websites like Myeloma.Trials.com can help patients find trials by disease type and location. There is also MMRF’s Community Gateway, which helps target patients through questions in a survey. She adds that few cancer trails consider the use of placebo drugs. She says phase 3 trials are “no-brainers” for patients.
Dr Kumar adds that clinical trials are important because they will be the future of myeloma treatment. Patients’ awareness of these trials is essential.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Culture Key to Data Collection of Sexual Orientation and Gender Identity in Cancer Care
June 23rd 2025This research highlights the key factors, like leadership buy-in, mandatory protocols, and electronic health record workflows, that influence the effective collection of data on sexual orientation and gender identity in outpatient oncology clinics to improve patient-centered care.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
